Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Get Alerts CXM Hot Sheet
Price: $11.84 -1.17%
EPS Growth %: +16.7%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +16.7%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!